 |
 |
"Preladenant is in the category called A2A or adenosine 2A inhibitors. And what these medications do is they interact with the dopamine system in the brain but they're unique and different because they're not dopamine." "Doctor Hauser says if all goes well with FDA approval, perhaps as soon as two to three years from now, it will be the first non-dopamine treatment for Parkinson’s Disease." What are these people smoking..?? Nic 59/17 On 29 June 2011 07:01, Rayilyn Brown <[log in to unmask]> wrote: > http://www2.tricities.com/news/2011/jun/27/promising-new-parkinsons-disease-drug-ar-1136973/ > > Ray > Rayilyn Brown > Past Director AZNPF > Arizona Chapter National Parkinson Foundation > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn